Impairment in the PI3K/Akt pathway is associated with glucose intolerance and insulin resistance as well as increased expression of phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase), two rate-limiting enzymes for hepatic glucose production [13], [14]. Here, AKT1 is linked to Glucose intolerance.